The number of U.S. biomedical postdoctoral fellows has fallen for three years in a row, an unprecedented decline that UAB's Louis Justement, Ph.D., and colleagues at the Federation of American Societies for Experimental Biology and Brown University call “an end to the era of expansion.”
Researchers have received funding to seek and validate biomarkers for the progressive, inherited disease Friedreich’s ataxia, a life-shortening degenerative neuromuscular disorder.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
Physicians embarked on a rare operation in an effort to save the lives of one Georgian, one Alabamian.
Researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA.
Engineers, physicians, computer scientists and statisticians will collaborate to research and apply big data in the health care, industrial and smart cities fields.
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
Valve-in-valve treatments are becoming more necessary as patients get older and outlive their original replacement heart valves.